Fibromyalgia syndrome: Current concepts in pathophysiology, clinical features, and management

Arthritis and Rheumatism

Volumn 9, Issue 4, 1996, Pages 315-328

  Simms, Robert W ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CYCLOBENZAPRINE; PSYCHOTROPIC AGENT; SEROTONIN; TRICYCLIC ANTIDEPRESSANT AGENT;

BRAIN BLOOD FLOW; CHRONIC FATIGUE SYNDROME; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ELECTROMYOGRAM; FIBROMYALGIA; FUNCTIONAL DISEASE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; KINESIOTHERAPY; MAJOR CLINICAL STUDY; MENTAL DISEASE; MULTICENTER STUDY; MYOFASCIAL PAIN; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SIDE EFFECT; SLEEP;

EID: 84988267196     PISSN: 0004-3591     EISSN: 1529-0131     Source Type: Journal    
DOI: 10.1002/1529-0131(199608)9:4<315::AID-ANR1790090417>3.0.CO;2-F     Document Type: Review

References (124)

1. Reynolds MD: The development of the concept of fibrositis. J Hist Med Allied Sci 38:5-35, 1983
2. Goldenberg D: Fibromyalgia: why such controversy? Ann Rheum Dis 54:3-5, 1995
3. Carette S: Fibromyalgia 20 years later: what have we really accomplished (editorial)? J Rheumatol 22:590-594, 1995
4. Bartels EM, Danneskiold-Samsoe B: Histological abnormalities in muscle from patients with certain types of fibrositis. Lancet 1:755-757, 1986
5. Bengtsson A, Henriksson K, Larsson J: Muscle biopsy in fibromyalgia: light microscopial and histochemical findings. Scand J Rheumatol 15:1-6, 1986
6. Fassbender H: Pathology of Rheumatic Disease. New York, Springer-Verlag, 1975
7. Henriksson K, Bengtsson A, Larsson J, Lindstrom F, Thornell L: Muscle biospy findings of possible diagnostic importance in primary fibromyalgia (fibrositis, myofascial syndrome) (letter). Lancet iii:1395, 1982
8. Lund N, Bengtsson A, Thorborg P: Muscle tissue oxygen pressure in primary fibromyalgia. Scand J Rheumatol 15:165-173, 1986
9. 133xenon clearance from exercising muscle. Arthritis Rheum 32:454-460, 1989
10. Simms RW, Roy SH, Hrovat M, et al: Lack of association between fibromyalgia syndrome and abnormalities in muscle energy metabolism. Arthritis Rheum 37:794-800, 1994
11. 31P nuclear magnetic resonance spectra in the skeletal muscle of fibromyalgia patients. Arthritis Rheum 37:801-807, 1994
12. Simms R, Hrovat M: Role of phosphodiesters in muscles of patients with fibromyalgia syndrome (abstract). Arthritis Rheum 38 (suppl 9):S229, 1995
13. Zimmermann M: Pathophysiological mechanisms of fibromyalgia. Clin J Pain 7 (suppl 1):S8-S15, 1991
14. Simms RW: Is there muscle pathology in fibromyalgia syndrome? Rheum Dis Clin North Am 22:245-266, 1996
15. Moldofsky H, Scarisbrick P, England R, Smythe H: Musculoskeletal symptoms and non-REM sleep disturbance in patients with fibrositis syndrome and healthy subjects. Psychosom Med 37:341-351, 1975
16. Moldofsky H, Scarisbrick P: Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation. Psychosom Med 38:35-44, 1976
17. Moldofsky H, Warsh J: Plasma tryptophan and musculoskeletal pain in non-articular rheumatism ("fibrositis syndrome"). Pain 5:65-71, 1978
18. 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol 19: 104-109, 1992
19. Yunus MB, Dailey JW, Aldag JC, Masi AT, Jobe PC: Plasma and urinary catecholamines in primary fibromyalgia: a controlled study. J Rheumatol 19:95-97, 1992
20. Russell IJ, Vaeroy H, Javors M, Nyberg F: Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 35:550-556, 1992
21. Buskila D, Fefer P, Harman-Boehm I, et al: Assessment of nonarticular tenderness and prevalence of fibromyalgia in hyperprolactinemic women. J Rheumatol 20:2112-2115, 1994
22. Bennett RM, Clark SR, Campbell SM, Burckhardt CS: Low levels of somatomedin C in patients with the fibromyalgia syndrome: a possible link between sleep and muscle pain. Arthritis Rheum 35:1113-1116, 1992
23. Mountz JM, Bradley LA, Modell JG, et al: Fibromyalgia in women: abnormalities of regional cerebral blood flow in UIB thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum 38:926-938, 1995
24. Goldstein JA, Mena I, Yunus MB: Regional cerebral blood flow by SPECT in chronic fatigue syndrome with and without fibromyalgia syndrome (abstract). Arthritis Rheum 36 (suppl 9):S222, 1993
25. Crofford LJ, Pillemer SR, Kalogeras KT, et al: Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 37:1583-1592, 1994
26. Griep EN, Boersma JW, de Kloet ER: Altered reactivity of the hypothalamic-pituitary-adrenal axis in the primary fibromyalgia syndrome. J Rheumatol 20:469-474, 1993
27. Disdier P, Harle J-R, Brue T, et al: Severe fibromyalgia after hypophysectomy for Cushing's disease. Arthritis Rheum 34:493-495, 1991
28. White A: The fibromyalgia syndrome: electroacupuncture is a potentially valuable treatment (letter). BMJ 310:1406, 1995
29. Demitrack M, Dale J, Straus S, et al: Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 73:1224-1234, 1991
30. Neeck G, Riedel W: Neuromediator and hormonal perturbations in fibromyalgia syndrome: results of chronic stress? Baillieres Clin Rheumatol 8:763-775, 1994
31. Krishnan K: Pituitary and adrenal changes in depression. Psychiatr Ann 23:871-875, 1993
32. Hudson J, Hudson M: Endocrine dysfunction in anorexia nervosa and bulemia: comparison with abnormalities in other psychiatric disorders and disturbances due to metabolic factors. Psychiatr Dev 4:237-272, 1984
33. Clark S, Tindall E, Bennett RM: A double blind crossover trial of prednisone versus placebo in the treatment of fibrositis. J Rheumatol 12:980-983, 1985
34. Gordon R: The nature of fibrositis and the influence of psychological stress. Bull Rheum Dis 89-99, 1940
35. Goldenberg DL: An overview of psychologic studies in fibromyalgia. J Rheumatol 16 (Suppl 19):12-14, 1989
36. Kirmayer L, Robbins J, Kapusta M: Somatization and Arthritis Care and Research depression in fibromyalgia syndrome. Am J Psychiatry 145:950-954, 1988
37. Ahles TA, Khan SA, Yunus MB, Spiegel DA, Masi AT: Psychiatric status of patients with primary fibromyalgia, patients with rheumatoid arthritis, and subjects without pain: a blind comparison of DSM-III diagnoses. Am J Psychiatry 148:1721-1726, 1991
38. Hudson JI, Goldenberg DL, Pope HG Jr, Keck PE Jr, Schlesinger L: Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 92:363-367, 1992
39. Hudson JI, Pope HG: The concept of affective spectrum disorder: relationship to fibromyalgia and other syndromes of chronic fatigue and chronic muscle pain. Baillieres Clin Rheumatol 8:839-856, 1994
40. Taylor ML, Trotter DA, Csuka ME: The prevalence of sexual abuse in women with fibromyalgia. Arthritis Rheum 38:229-234, 1995
41. Boisset-Pioro MH, Esdaile JM, Fitzcharles M-A: Sexual and physical abuse in women with fibromyalgia syndrome. Arthritis Rheum 38:235-241, 1995
42. Hudson JI, Pope HG Jr: Does childhood sexual abuse cause fibromyalgia? Arthritis Rheum 38:161-163, 1995
43. Aaron LA, Bradley LA, Alarcón GS, et al: Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness. Arthritis Rheum 39:436-445, 1996
44. Wolfe F, Smythe HA, Yunus MB, et al: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 33:160-172, 1990
45. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L: The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38:19-28, 1995
46. Littlejohn G: The fibromyalgia syndrome. Outcome is good with minimal intervention. BMJ 310:1406, 1995
47. Hawley DJ, Wolfe F, Cathey MA: Pain, functional disability, and psychological status: a 12-month study of severity in fibromyalgia. J Rheumatol 15:1551-1556, 1988
48. Norregaard J, Bulow PM, Prescott E, Jacobsen S, Danneskiold-Samsoe B: A four-year follow-up study in fibromyalgia: relationship to chronic fatigue syndrome. Scand J Rheumatol 22:35-38, 1993
49. Kennedy MJ, Goldenberg DL, Felson DT: A prospective long-term study of fibromyalgia syndrome (abstract). Arthritis Rheum 37 (suppl 9):S213, 1994
50. Felson DT, Goldenberg DL: The natural history of fibromyalgia. Arthritis Rheum 29:1522-1526, 1986
51. Bohr T: Fibromyalgia syndrome and myofascial pain syndrome: do they exist? Neurol Clin 13:365-384, 1995
52. Bohr T: Problems with myofascial pain syndrome and fibromyalgia syndrome. Neurology 46:593-597, 1996
53. Cohen M, Quintner J: Fibromyalgia syndrome, a problem of tautology. Lancet 342:906-909, 1993
54. Lightfoot RW Jr, Michel BA, Bloch DA, et al: The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 33: 1088-1093, 1990
55. Hunder GG, Bloch DA, Michel BA: The American College of Rheumatology criteria for the classification of giant cell arteritis. Arthritis Rheum 33:1122-1128, 1990
56. Tan EM, Cohen AS, Fries JF, et al: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277, 1982
57. Arnett FC, Edworthy SM, Bloch DA, et al: The American Rheumatism Association 1987 revised criteria of the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324, 1988
58. Wolfe F: The fibromyalgia syndrome: a consensus report on fibromyalgia and disability. J Rheumatol 23: 534-539, 1996
59. Hadler N: A critical reappraisal of the fibrositis concept. Am J Med 81:26-30, 1986
60. Simms RW, Goldenberg DL: Symptoms mimicking neurologic disorders in fibromyalgia syndrome. J Rheumatol 15:1271-1273, 1988
61. Yunus M, Masi A, Calabro J, Miller K, Fiegenbaum S: Primary fibromyalgia (fibrositis): a clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 11:151-171, 1981
62. Simms RW, Goldenberg DL, Felson DT, Mason JH: Tenderness in 75 anatomic sites: distinguishing fibromyalgia patients from controls. Arthritis Rheum 31: 182-187, 1988
63. Langevitz P, Buskila D: Studying tenderness - a clue to understanding fibromyalgia. Isr J Med Sci 28:41-42, 1992
64. Tunks E, Crook J, Norman G, Kalaher S: Tender points in fibromyalgia. Pain 34:11-19, 1988
65. Quimby LC, Block SR, Gratwick GM: Fibromyalgia: generalized pain intolerance and manifold symptom reporting. J Rheumatol 15:1264-1270, 1988
66. Wolfe F, Ross K, Anderson J, Russell IJ: Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms. J Rheumatol 22:151-156, 1995
67. Croft P, Schollum J, Silman A: Population study of tender point counts and pain as evidence of fibromyalgia. BMJ 309:696-699, 1994
68. Croft P, Rigby AS, Boswell R, Schollum J, Silman A: The prevalence of chronic widespread pain in the general population. J Rheumatol 20:710-713, 1993
69. Goldenberg DL, Simms RW, Geiger A, Komaroff AL: High frequency of fibromyalgia in patients with chronic fatigue seen in a primary care practice. Arthritis Rheum 33:381-387, 1990
70. Buchwald D, Garrity D: Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. Arch Intern Med 154:2049-2053, 1994
71. Goldenberg DL: Fibromyalgia, chronic fatigue syndrome, and myofascial pain syndrome. Curr Opin Rheumatol 6:223-233, 1994
72. Hudson JI, Pope HG Jr: Fibromyalgia and psychopathology: is fibromyalgia a form of "affective spectrum disorder?" J Rheumatol 16 (Suppl 19):15-22, 1989
73. Smythe H: Links between fibromyalgia and myofascial pain syndromes. J Rheumatol 19:842-843, 1992
74. Wolfe F, Simons DG, Fricton J, et al: The fibromyalgia and myofascial pain syndromes: a preliminary study of tender points and trigger points in persons with fibromyalgia, myofascial pain syndrome and no disease. J Rheumatol 19:944-951, 1992
75. Goldenberg D: Fibromyalgia. In, Rheumatology. Edited by JH Klippel, PA Dieppe. St. Louis, Mosby, 1994
76. Nash P, Chard M, Hazleman B: Chronic coxsackie B infection mimicking primary fibromyalgia. J Rheumatol 16:1506-1508, 1989
77. Leventhal LJ, Naides SJ, Freundlich B: Fibromyalgia and parvovirus infection. Arthritis Rheum 34:1319-1324, 1991
78. Berg AM, Naides SJ, Simms RW: Established fibromyalgia syndrome and parvovirus B19 infection. J Rheumatol 20:1941-1943, 1993
79. Simms RW, Zerbini CA, Ferrante N, Anthony J, Felson DT, Craven DE: Fibromyalgia syndrome in patients infected with human immunodeficiency virus. Am J Med 92:368-374, 1992
80. Dinerman H, Steere A: Lyme disease associated with fibromyalgia. Ann Intern Med 117:281-285, 1993
81. Middleton GD, McFarlin JE, Lipsky PE: The prevalence and clinical impact of fibromyalgia in systemic lupus erythematosus. Arthritis Rheum 37:1181-1188, 1994
82. Simms RW: Controlled trials of therapy in fibromyalgia syndrome. Baillieres Clin Rheumatol 8:917-934, 1994
83. Moldofsky H, Lue F: The relationship of alpha and delta EEG frequencies to pain and mood in fibrositis patients treated with chlorpromazine and L-tryptophan. Electroencephalogr Clin Neurophysiol 50:71-80, 1980
84. Potter W, Rudorfer M, Manjii H: The pharmacologic treatment of depression. N Engl J Med 325:633-642, 1991
85. Goldenberg DL, Felson DT, Dinerman H: A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum 29:1371-1377, 1986
86. Carrette S, McCain GA, Bell DA, Fam AG: Evaluation of amitriptyline in primary fibrositis: a double-blind, placebo-controlled study. Arthritis Rheum 29:655-659, 1986
87. Jaeschke R, Adachi J, Guyatt G, Keller J, Wong B: Clinical usefulness of amitriptyline in fibromyalgia: the results of 23 N-of-1 randomized controlled trials. J Rheumatol 18:447-451, 1991
88. Barnes C, Fung S, GintautusJ: Brainstem noradrenergic system depression by cyclobenzaprine. Neuropharmacology 19:221-224, 1980
89. Bennett RM, Gatter RA, Campbell SM, et al: A comparison of cyclobenzaprine and placebo in the management of fibrositis: a double-blind, controlled study. Arthritis Rheum 31:1535-1542, 1988
90. Carette S, Bell MJ, Reynolds WJ, et al: Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia: a randomized, double-blind clinical trial. Arthritis Rheum 37:32-40, 1994
91. Simms RW, Felson DT, Goldenberg DL: Development of preliminary criteria for response to treatment in fibromyalgia syndrome. J Rheumatol 18:1558-1563, 1991
92. Wolfe F, Cathey MA, Hawley DJ: A double-blind placebo controlled trial of fluoxetine in fibromyalgia. Scand J Rheumatol 23:255-259, 1994
93. Russell IJ, Fletcher EM, Michalek JE, McBroom PC, Hester GG: Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam: a double-blind, placebo-controlled study. Arthritis Rheum 34:552-560, 1991
94. Yunus MB, Masi AT, Aldag JC: Short term effects of ibuprofen in primary fibromyalgia syndrome: a double blind, placebo controlled trial. J Rheumatol 16:527-532, 1989
95. Vaeroy H, Abrahamsen A, Forre O, Kass E: Treatment of fibromyalgia (fibrositis syndrome): a parallel double blind trial with carisprodol, paracetamol and caffeine (Somadril comp) versus placebo. Clin Rheumatol 8: 245-250, 1989
96. McCain GA, Bell DA, Mai FM, Halliday PD: A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia. Arthritis Rheum 31:1135-1141, 1988
97. Ferraccioli G, Fhirelli L, Scita F, et al: EMG-biofeedback training in fibromyalgia syndrome. J Rheumatol 14:820-825, 1987
98. Wolfe F: Fibromyalgia: whither treatment? J Rheumatol 15:1047-1049, 1988
99. Riet GT, Kleijnen J, Knipshild P: Acupuncture and chronic pain: a criteria-based meta-analysis. J Clin Epidemiol 43:1191-1199, 1990
100. Patel M, Gutzwiller F, Pacaud F, et al: A meta-analysis of acupuncture for the treatment of pain: a review of evaluative research. Pain 24:15-40, 1986
101. Deluze C, Bosia L, Zirbs A, et al: Electroacupuncture in fibromyalgia: results of a controlled trial. BMJ 305: 1249-1252, 1992
102. Haanen HCM, Hoenderdos HTW, Van Romunde LKJ, et al: Controlled trial of hypnotherapy in the treatment of refractory fibromyalgia. J Rheumatol 18:72-75, 1991
103. Masi A, Yunus M: Fibrornyalgia - which is the best treatment? A personalized, comprehensive, ambulatory, patient-involved management program. Baillieres Clin Rheumatol 4:333-370, 1990
104. Sheon R, Moskowitz R, Goldberg V: Intralesional soft tissue injection technique. In, Soft Tissue Rheumatic Pain: Recognition, Management, Prevention. Second edition. Philadelphia, Lea and Febiger, 1987
105. Yunus M: Diagnosis, etiology and management of fibromyalgia syndrome: an update. Comp Ther 14:8-20, 1988
106. McCain G: Non-medicinal treatments in primary fibromyalgia. Rheum Dis Clin North Am 15:73-90, 1989
107. Kaada B: Treatment of fibromyalgia by low-frequency transcutaneous nerve stimulation. Tidsskrift For Den Norske Laegeforening 109:2992-2995, 1989
108. Deyo R, Walsh N, Martin D: A controlled trial of transcutaneous electrical nerve stimulation (TENS) and exercise for chronic low back pain. N Engl J Med 322: 1627-1634, 1990
109. Bradley LA, Young LD, Anderson KO, et al: Effects of psychological therapy on pain behavior of rheumatoid arthritis patients: treatment outcome and six-month followup. Arthritis Rheum 30:1105-1114, 1987
110. Parker JC, Frank RG, Beck NC: Pain management in rheumatoid arthritis patients: a cognitive-behavioral approach. Arthritis Rheum 31:593-601, 1988
111. Nielson WR, Walker C, McCain GA: Cognitive behavioral treatment of fibromyalgia syndrome: preliminary findings. J Rheumatol 19:98-103, 1992
112. Goldenberg DL, Kaplan KH, Nadeau MG: The impact of cognitive-behavioral therapy on fibromyalgia (abstract). Arthritis Rheum 34 (suppl 9):S190, 1991
113. Bennett R, Campbell S, Burkhardt C: A multidisciplinary approach to fibromyalgia management. J Musculoskeletal Med 8:21-32, 1991
114. Anonymous: Does fibromyalgia qualify as a work-related illness or injury? J Occup Med 34:968, 1992
115. Bohr TW: Fibromyalgia syndrome and myofascial pain syndrome: do they exist? Neurol Clin 13:365-384, 1995
116. Bruusgaard D, Evensen AR, Bjerkedal T: Fibromyalgia - a new cause for disability pension. Scand J Soc Med 21:116-119, 1993
117. Capen K: The courts, expert witnesses and fibromyalgia. Can Med Assoc J 153:206-208, 1995
118. Hidding A, van Santen M, De Klerk E, et al: Comparison between self-report measures and clinical observations of functional disability in ankylosing spondylitis, rheumatoid arthritis and fibromyalgia. J Rheumatol 21:818-823, 1994
119. Nordstrom D: Disabling fibromyalgia: appearance vs reality (letter). J Rheumatol 21:1776, 1994
120. Reid GD: Disabling fibromyalgia: appearance vs reality (letter). J Rheumatol 21:1578, 1994
121. Rush PJ, Ameis A: Trauma and fibromyalgia: does the punishment fit the crime? (letter). J Rheumatol 22:372-373, 1995
122. Russell AS, Percy JS: Disabling fibromyalgia: appearance vs reality (letter). J Rheumatol 21:1580, 1994
123. White KP, Harth M, Teasell RW: Work disability evaluation and the fibromyalgia syndrome. Semin Arthritis Rheum 24:371-381, 1995
124. Moldofsky H, Wong MTH, Lue FA: Litigation, sleep, symptoms and disabilities in postaccident pain (fibromyalgia). J Rheumatol 20:1935-1940, 1993